Barbed Reposition Pharyngoplasty in Patients Complaining of Unilevel Palatal Snoring
Patient-reported Outcomes of Barbed Reposition Pharyngoplasty in Unilevel Palatal Snoring: a Prospective Study
1 other identifier
interventional
16
1 country
1
Brief Summary
The aim of the study is to determine whether there is a statistically significant difference in snoring intensity before and after performing a Barbed Reposition Pharyngoplasty as a single-level snoring procedure. The investigators aim to determine whether this is a valid alternative to the more classical techniques of pharyngoplasty. Furthermore, the investigators also wish to map the various postoperative complications and compare them with those of the more conventional techniques. The investigators compare the snoring intensity before surgery with the snoring intensity at 2 weeks (first postoperative control), at 6 weeks (second postoperative control) and at 6 months (Third postoperative control). For the evaluation of snoring, the investigators use 4 scales/questionnaires. These questionnaires are currently also used as standard at the outpatient clinic for snoring problems. These 4 scales/questionnaires are completed at every check-up. During the first postoperative check-up, the postoperative side effects are checked (bleeding, infection, readmission, needed consultation with another doctor, date of resumption of work). The investigators also map the pain with a visual analog scale and measure this the day after the operation and let the patient fill it in 3 days, 1 week and 2 weeks after the operation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2022
CompletedFirst Submitted
Initial submission to the registry
November 23, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedFirst Posted
Study publicly available on registry
December 8, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2023
CompletedDecember 8, 2022
December 1, 2022
2 months
November 23, 2022
December 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Snoring intensity
Seld-reported subjective score from 0 to 10 that describes the impact of snoring with 0 meaning no snoring and 10 meaning sleeping separately from partner
At 2 weeks, at 6 weeks and at 6 months
Change in Snoring severity
Seld-reported subjective score that describes the severity of snoring (frequency, duration,...). Score from 0 to 9 with 0 meaning never snoring and 9 meaning snoring every night during the entire night with sounds audible from another floor
At 2 weeks, at 6 weeks and at 6 months
Change in Snoring score
Seld-reported subjective score that describes the overall loudness of snoring with score of 0 meaning no snoring and 10 meaning extreme snoring
At 2 weeks, at 6 weeks and at 6 months
Secondary Outcomes (1)
Change in Epworth Sleepiness Scale
At 2 weeks, at 6 weeks and at 6 months
Interventions
Barbed reposition pharyngoplasty was performed in all patients
Eligibility Criteria
You may qualify if:
- single-level retro-palatal collapse observed during drug-induced sleep endoscopy (DISE)
You may not qualify if:
- OSAS defined as having an obstructive AHI (OAHI) ≥ 30
- Obese patients with a body mass index (BMI) ≥ 30 kg/m².
- Patients with multilevel airway collapse observed during DISE
- Patients younger than 18 years old.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AZ Deltalead
Study Sites (1)
Neus-, keel- en oorziekten, gelaats- en halschirurgie AZ Delta
Roeselare, 8800, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 23, 2022
First Posted
December 8, 2022
Study Start
October 1, 2022
Primary Completion
December 1, 2022
Study Completion
February 1, 2023
Last Updated
December 8, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share